New Delhi News

Atopic Dermatitis Epidemiology Forecast Report 2030 | Atopic Dermatitis Epidemiology Analysis 2030 | DelveInsight

 Breaking News
  • No posts were found

Atopic Dermatitis Epidemiology Forecast Report 2030 | Atopic Dermatitis Epidemiology Analysis 2030 | DelveInsight

September 07
17:20 2021
Atopic Dermatitis Epidemiology Forecast Report 2030 | Atopic Dermatitis Epidemiology Analysis 2030 | DelveInsight
DelveInsight Business Research LLP
DelveInsight’s ‘Atopic Dermatitis (AD) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Atopic Dermatitis (AD) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

DelveInsight launched a new report on Atopic Dermatitis Epidemiology Forecast, 2030.

Atopic dermatitis (eczema) is a condition that makes your skin red and itchy. It’s common in children but can occur at any age. Atopic dermatitis is long-lasting (chronic) and tends to flare periodically. It may be accompanied by asthma or hay fever.

DelveInsight’s ‘Atopic Dermatitis Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Atopic Dermatitis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Some of the key highlights from the Atopic Dermatitis Epidemiology Report:

  1. The total prevalent population of AD in the United States was estimated to be 32,197,083 in 2020, out of which 13,313,991 cases were in the child population and 18,883,091 cases were in adults.

  2. The total diagnosed prevalent population of AD in the United States was 25,091,967 in 2020.

  3. The prevalent population of AD in the United States is expected to increase at a CAGR of 0.55% during the forecast period 2021–2030.

  4. In 2020, the total prevalence of AD in adults in the United States was 5,684,566 in males and 9,421,907 in females. 

Visit for more @ Atopic Dermatitis Epidemiology Insights

Scope of the Atopic Dermatitis Epidemiology report:

  1. The Atopic Dermatitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns

  2. The Atopic Dermatitis Epidemiology Report and Model provide an overview of the risk factors and global trends of Atopic Dermatitis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)

  3. The report provides insight into the historical and forecasted patient pool of Atopic Dermatitis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan

  4. The report helps to recognize the growth opportunities in the 7MM concerning the patient population

  5. The report assesses the disease risk and burden and highlights the unmet needs of Atopic Dermatitis

  6. The report provides the segmentation of the Atopic Dermatitis epidemiology

Table of Contents:

1. Key Insights

2. Executive Summary of Atopic Dermatitis

3. Atopic Dermatitis Epidemiology Overview at a Glance

4. Atopic Dermatitis: Disease Background and Overview

5. Epidemiology and Patient Population

6. Case Reports

7. Country Wise-Epidemiology of Atopic Dermatitis 

8. Appendix

9. DelveInsight Capabilities

10.Disclaimer

11.About DelveInsight

Related Reports:

Atopic Dermatitis Market

DelveInsight’s ‘Atopic Dermatitis-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom), 

Atopic Dermatitis Pipeline 

“Atopic Dermatitis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Atopic Dermatitis market. A detailed picture of the Atopic Dermatitis pipeline landscape is provided, which includes the disease overview and Atopic Dermatitis treatment guidelines.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles